TACTILE SYSTEMS TECHNOLOGY I (TCMD)
US87357P1003 - Common Stock
TCMD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. TCMD has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. TCMD has a correct valuation and a medium growth rate. These ratings could make TCMD a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
In the past year TCMD was profitable.
In the past year TCMD had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: TCMD reported negative net income in multiple years.
Each year in the past 5 years TCMD had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 11.69%, TCMD belongs to the best of the industry, outperforming 93.05% of the companies in the same industry.
With an excellent Return On Equity value of 16.24%, TCMD belongs to the best of the industry, outperforming 93.05% of the companies in the same industry.
With an excellent Return On Invested Capital value of 7.32%, TCMD belongs to the best of the industry, outperforming 85.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.69% | ||
| ROE | 16.24% | ||
| ROIC | 7.32% |
ROA(3y)-0.57%
ROA(5y)1.04%
ROE(3y)-3.07%
ROE(5y)0.01%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 11.58%, TCMD belongs to the best of the industry, outperforming 87.70% of the companies in the same industry.
TCMD's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 8.05%, TCMD is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
In the last couple of years the Operating Margin of TCMD has grown nicely.
TCMD has a Gross Margin (50.63%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of TCMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.05% | ||
| PM (TTM) | 11.58% | ||
| GM | 50.63% |
OM growth 3YN/A
OM growth 5Y25.8%
PM growth 3YN/A
PM growth 5Y17.75%
GM growth 3Y1.41%
GM growth 5Y0.89%
2. Health
2.1 Basic Checks
TCMD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
TCMD has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, TCMD has more shares outstanding
Compared to 1 year ago, TCMD has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.76 indicates that TCMD is not in any danger for bankruptcy at the moment.
TCMD's Altman-Z score of 4.76 is fine compared to the rest of the industry. TCMD outperforms 75.94% of its industry peers.
TCMD has a debt to FCF ratio of 0.81. This is a very positive value and a sign of high solvency as it would only need 0.81 years to pay back of all of its debts.
TCMD has a better Debt to FCF ratio (0.81) than 90.91% of its industry peers.
TCMD has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
TCMD's Debt to Equity ratio of 0.12 is in line compared to the rest of the industry. TCMD outperforms 56.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 0.81 | ||
| Altman-Z | 4.76 |
ROIC/WACC0.79
WACC9.22%
2.3 Liquidity
A Current Ratio of 4.44 indicates that TCMD has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.44, TCMD is in the better half of the industry, outperforming 68.98% of the companies in the same industry.
TCMD has a Quick Ratio of 3.89. This indicates that TCMD is financially healthy and has no problem in meeting its short term obligations.
TCMD has a better Quick ratio (3.89) than 72.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.44 | ||
| Quick Ratio | 3.89 |
3. Growth
3.1 Past
The earnings per share for TCMD have decreased strongly by -38.89% in the last year.
The Earnings Per Share has been growing by 20.62% on average over the past years. This is a very strong growth
The Revenue has grown by 11.19% in the past year. This is quite good.
The Revenue has been growing by 13.80% on average over the past years. This is quite good.
EPS 1Y (TTM)-38.89%
EPS 3Y121.78%
EPS 5Y20.62%
EPS Q2Q%-77.66%
Revenue 1Y (TTM)11.19%
Revenue growth 3Y13.62%
Revenue growth 5Y13.8%
Sales Q2Q%5.04%
3.2 Future
Based on estimates for the next years, TCMD will show a decrease in Earnings Per Share. The EPS will decrease by -1.25% on average per year.
TCMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.29% yearly.
EPS Next Y-47.47%
EPS Next 2Y-14.45%
EPS Next 3Y-1.25%
EPS Next 5YN/A
Revenue Next Year6.42%
Revenue Next 2Y8.13%
Revenue Next 3Y8.29%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 24.15 indicates a rather expensive valuation of TCMD.
85.03% of the companies in the same industry are more expensive than TCMD, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 28.96. TCMD is around the same levels.
With a Price/Forward Earnings ratio of 18.15, TCMD is valued on the expensive side.
Based on the Price/Forward Earnings ratio, TCMD is valued cheaply inside the industry as 86.63% of the companies are valued more expensively.
TCMD is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.82, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.15 | ||
| Fwd PE | 18.15 |
4.2 Price Multiples
94.12% of the companies in the same industry are more expensive than TCMD, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, TCMD is valued cheaper than 96.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.21 | ||
| EV/EBITDA | 10.26 |
4.3 Compensation for Growth
The decent profitability rating of TCMD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.17
EPS Next 2Y-14.45%
EPS Next 3Y-1.25%
5. Dividend
5.1 Amount
TCMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TACTILE SYSTEMS TECHNOLOGY I
NASDAQ:TCMD (11/21/2024, 8:00:01 PM)
After market: 16.1905 +0.25 (+1.57%)15.94
+0.38 (+2.44%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap382.56M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.15 | ||
| Fwd PE | 18.15 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)1.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.69% | ||
| ROE | 16.24% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 8.05% | ||
| PM (TTM) | 11.58% | ||
| GM | 50.63% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 4.44 | ||
| Quick Ratio | 3.89 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-38.89%
EPS 3Y121.78%
EPS 5Y
EPS Q2Q%
EPS Next Y-47.47%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)11.19%
Revenue growth 3Y13.62%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y